Medtronic reports first quarter fiscal 2023 financial results

Go back to Medtronic reports first quarter fiscal 2023 financial results

Medtronic (MDT) Downgraded by Raymond James on Growing Impatience

August 24, 2022 12:31 PM EDT

Shares of Medtronic (NYSE: MDT) were downgraded to Market Perform from Outperform by Raymond James analyst Jayson Bedford on Wednesday, stating that the firm is "growing impatient."

Bedford downgraded the stock following its fiscal Q1 earnings release on Tuesday, stating the company's... More

Medtronic (MDT) Tops Q1 EPS by 1c; Offers FY23 EPS Guidance

August 23, 2022 6:47 AM EDT

Medtronic (NYSE: MDT) reported Q1 EPS of $1.13, $0.01 better than the analyst estimate of $1.12. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $7.22 billion.

GUIDANCE:

Medtronic sees FY2023 EPS of $5.53-$5.65, versus the consensus of $5.56.

For earnings history and earnings-related data on Medtronic (MDT) click here.

... More